tiprankstipranks
Trending News
More News >

Hemogenyx Pharmaceuticals Announces Total Voting Rights Update

Story Highlights
Hemogenyx Pharmaceuticals Announces Total Voting Rights Update

Confident Investing Starts Here:

The latest announcement is out from HemoGenyx Pharmaceuticals Plc ( (GB:HEMO) ).

Hemogenyx Pharmaceuticals announced its total issued share capital consists of 4,343,539 ordinary shares, with no shares held in treasury. This figure is crucial for shareholders to determine their investment status under the Financial Conduct Authority’s rules, impacting how they manage their interests in the company’s share capital.

More about HemoGenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals is a publicly traded clinical stage biopharmaceutical company headquartered in London, with US subsidiaries in New York City. The company focuses on developing new medicines and treatments for blood and autoimmune diseases, utilizing several product candidates and platform technologies.

Average Trading Volume: 40,789

Technical Sentiment Signal: Sell

Current Market Cap: £7.71M

Learn more about HEMO stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1